These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8754541)

  • 1. [The use of tactivin in the combined treatment and prevention of complications in reconstructive operations on the bones of the facial skeleton].
    Volozhin AI; Sazhina TG; Chergeshtov IuI; Arion VIa; Panin MG; Shipkova TP
    Stomatologiia (Mosk); 1996; 75(2):46-8. PubMed ID: 8754541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Arion VIa; Sysoeva OP; Krugliakova EP
    Stomatologiia (Mosk); 1996; 75(2):31-3. PubMed ID: 8754536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of tactivin for treating patients with IHD].
    Klimov AN; Almazov VA; Nagornev VA; Denisenko AD; Pigarevskiĭ PV; Ogurtsov RP; Sergeeva EG; Sitnikova OD; Popov VG
    Ter Arkh; 1995; 67(9):24-7. PubMed ID: 7495034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tactivin in combined treatment of patients with pulmonary tuberculosis associated with gastrointestinal diseases].
    Zhukova EM
    Probl Tuberk; 1995; (3):25-7. PubMed ID: 7617628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T-cell immunity and immunomodulators in the comprehensive treatment of diffuse toxic goiter].
    Petunina NA; Balabolkin MI; Arion VIa
    Ross Med Zh; 1992; (5-12):19-24. PubMed ID: 1286263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T-activin in the treatment of patients with recurrent aphthous stomatitis].
    Terekhova NV; Khazanova VV; Zemskaia EA; Bykova IA; Filonenko OF; Kosorukova NIa; Rabinovich IM
    Stomatologiia (Mosk); 1991; (2):35-7. PubMed ID: 1853375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endovascular surgery and the validation of immunocorrection in patients with liver cirrhosis complicated by portal hypertension].
    Karimov ShI; Kim VF; Iunusov IR
    Vestn Khir Im I I Grek; 1991 May; 146(5):26-8. PubMed ID: 1668432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An ultrastructural and morphometric analysis of the polymorphonuclear leukocytes from lesion foci and from the peripheral blood in patients with a gonorrhea-chlamydial urogenital infection before and during treatment with doxycycline combined with T-activin].
    Delektorskiĭ VV; Danielian EE; Iashkova GN; Kubanova AA; Khachikian KhM
    Vestn Dermatol Venerol; 1990; (2):15-21. PubMed ID: 2343663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and treatment of postoperative complications of hepatic echinococcosis].
    Akhmedov RM; Ochilov UB; Mirkhodzhaev IA; Komilov TS; Makliev BIu
    Med Parazitol (Mosk); 2003; (2):18-21. PubMed ID: 12886586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
    Shafer NP
    Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-immunologic effect of tactivin in chronic myeloid leukemia].
    Abdulkadyrov KM; Guseva SA
    Gematol Transfuziol; 1994; 39(5):19-22. PubMed ID: 7896024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of tactivin and imunofan for the treatment of patients with endometrial carcinoma].
    Venediktova MG
    Eksp Klin Farmakol; 2001; 64(5):46-9. PubMed ID: 11764501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined detoxification and immunocorrective therapy in patients with peritonitis].
    Shkrob LO; Fedotov PA; Ermakova NG
    Khirurgiia (Mosk); 1994 Mar; (3):20-2. PubMed ID: 8007606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of taktivin for modulating the functional activity of the neutrophilic granulocytes in patients with systemic lupus erythematosus].
    Romanov VA; Borodin AG; Krylov VL
    Ter Arkh; 1992; 64(5):65-9. PubMed ID: 1455381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon and tactivin in the treatment program for non-Hodgkin's lymphomas in children during remission].
    Makhonova LA; Kiselev AV; Gordina GA; Kadagidze ZG
    Vopr Onkol; 1995; 41(2):80-1. PubMed ID: 7483451
    [No Abstract]   [Full Text] [Related]  

  • 16. [A clinico-immunological assessment of the efficacy of combined methods of treating patients with different immunopathological forms of focal scleroderma].
    Suchkova TN; Sharova NM; Suchkov SV
    Vestn Dermatol Venerol; 1990; (2):47-50. PubMed ID: 2343669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of tactivin side effects in patient with eczema].
    Zaerko VV
    Klin Med (Mosk); 1991 May; 69(5):97-8. PubMed ID: 1857089
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of taktivin in experimental apical periodontitis exacerbated by a secondary immunodeficiency state].
    Zyrianov GV; Dmitrieva LA; Frolova TM; Belopol'skiĭ AA; Babaian SS
    Stomatologiia (Mosk); 1993; 72(2):10-3. PubMed ID: 8048117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
    Arion VIa; Bekman EM; Tiurin NA; Mazurina NA; Filimonova AV
    Biull Eksp Biol Med; 1994 Nov; 118(11):496-8. PubMed ID: 7888649
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunocorrective therapy of pyelonephritis in children].
    Kirillov VI; Zernov NG; Arion VIa; Tebloeva LT; Riabchikov OP
    Urol Nefrol (Mosk); 1989; (5):17-21. PubMed ID: 2595860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.